Literature DB >> 21502944

Protein aggregation: p53 succumbs to peer pressure.

Mazin Magzoub, Andrew D Miranker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21502944     DOI： 10.1038/nchembio.569

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN： 1552-4450            Impact factor:   15.040


× No keyword cloud information.
  10 in total

1.  Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins.

Authors:  Ana-Maria Fernandez-Escamilla; Frederic Rousseau; Joost Schymkowitz; Luis Serrano
Journal:  Nat Biotechnol       Date:  2004-09-12       Impact factor: 54.908

2.  Fiber-dependent amyloid formation as catalysis of an existing reaction pathway.

Authors:  Amy M Ruschak; Andrew D Miranker
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-17       Impact factor: 11.205

3.  Atomic structures of amyloid cross-beta spines reveal varied steric zippers.

Authors:  Michael R Sawaya; Shilpa Sambashivan; Rebecca Nelson; Magdalena I Ivanova; Stuart A Sievers; Marcin I Apostol; Michael J Thompson; Melinda Balbirnie; Jed J W Wiltzius; Heather T McFarlane; Anders Ø Madsen; Christian Riekel; David Eisenberg
Journal:  Nature       Date:  2007-04-29       Impact factor: 49.962

Review 4.  The interplay of catalysis and toxicity by amyloid intermediates on lipid bilayers: insights from type II diabetes.

Authors:  James A Hebda; Andrew D Miranker
Journal:  Annu Rev Biophys       Date:  2009       Impact factor: 12.981

5.  Identifying the amylome, proteins capable of forming amyloid-like fibrils.

Authors:  Lukasz Goldschmidt; Poh K Teng; Roland Riek; David Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-03       Impact factor: 11.205

6.  Gain of function of mutant p53 by coaggregation with multiple tumor suppressors.

Authors:  Jie Xu; Joke Reumers; José R Couceiro; Frederik De Smet; Rodrigo Gallardo; Stanislav Rudyak; Ann Cornelis; Jef Rozenski; Aleksandra Zwolinska; Jean-Christophe Marine; Diether Lambrechts; Young-Ah Suh; Frederic Rousseau; Joost Schymkowitz
Journal:  Nat Chem Biol       Date:  2011-03-27       Impact factor: 15.040

Review 7.  Mutant p53 gain-of-function in cancer.

Authors:  Moshe Oren; Varda Rotter
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02       Impact factor: 10.005

Review 8.  Are interactions with p63 and p73 involved in mutant p53 gain of oncogenic function?

Authors:  Y Li; C Prives
Journal:  Oncogene       Date:  2007-04-02       Impact factor: 9.867

Review 9.  The tumor suppressor p53: from structures to drug discovery.

Authors:  Andreas C Joerger; Alan R Fersht
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02-10       Impact factor: 10.005

10.  A peptidomimetic approach to targeting pre-amyloidogenic states in type II diabetes.

Authors:  James A Hebda; Ishu Saraogi; Mazin Magzoub; Andrew D Hamilton; Andrew D Miranker
Journal:  Chem Biol       Date:  2009-09-25
  10 in total
  3 in total

1.  Hsp90 inhibition renders iNOS aggregation and the clearance of iNOS aggregates by proteasomes requires SPSB2.

Authors:  Tingting Wang; Suxin Luo; Honghua Qin; Yong Xia
Journal:  Free Radic Biol Med       Date:  2018-01-31       Impact factor: 7.376

2.  Protein mimetic amyloid inhibitor potently abrogates cancer-associated mutant p53 aggregation and restores tumor suppressor function.

Authors:  L Palanikumar; Laura Karpauskaite; Mohamed Al-Sayegh; Ibrahim Chehade; Maheen Alam; Sarah Hassan; Debabrata Maity; Liaqat Ali; Mona Kalmouni; Yamanappa Hunashal; Jemil Ahmed; Tatiana Houhou; Shake Karapetyan; Zackary Falls; Ram Samudrala; Renu Pasricha; Gennaro Esposito; Ahmed J Afzal; Andrew D Hamilton; Sunil Kumar; Mazin Magzoub
Journal:  Nat Commun       Date:  2021-06-25       Impact factor: 14.919

Review 3.  Aggregation and Prion-Like Properties of Misfolded Tumor Suppressors: Is Cancer a Prion Disease?

Authors:  Danielly C F Costa; Guilherme A P de Oliveira; Elio A Cino; Iaci N Soares; Luciana P Rangel; Jerson L Silva
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-10-03       Impact factor: 10.005
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.